KAE609 shows promise as next generation treatment for malaria
KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over...
KAE609 is the first antimalarial drug candidate with a novel mechanism of action to achieve positive clinical proof-of-concept in over...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on Gilead...
Collaboration aims to create and commercialize companion diagnostic using genomic data from plasma samples to guide the use of IRESSA...
Priorclave has launched the MVA C40 benchtop vacuum autoclave, meeting requirements of laboratories wanting to perform low-volume sterilisation of items...
CTI BioPharma Corp. (CTI) (nasdaq and mta:CTIC) announced today that it will report its second quarter 2014 financial results on...
Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights India Business grew by 20.87% to Rs....
Maximum ease of cleaning, maintenance and internal inspection: a mix of qualities that make CosmoDry System® the ideal solution even...
LSI Medience Corporation today announced that the company has signed an Agreement with Kineticos, a Raleigh-Durham, NC based life sciences...
Mezzion Pharma Co. Ltd., announced that it has initiated a clinical program to evaluate the use of udenafil to treat...
SVP IX fund to invest primarily in late-stage biopharmaceutical companies. Sofinnova Ventures, a Menlo Park based investment firm, today announced...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.